ConductScience.org, home

Paper40124344

Treatment of lung diseases via nanoparticles and nanorobots: Are these viable alternatives to overcome current treatments?

George M and 3 others. Mater Today Bio, 2025. Cited by 10 papers, by iCite.

Cite this record

ConductScience Library. Treatment of lung diseases via nanoparticles and nanorobots: Are these viable alternatives to overcome current treatments? Papers, record 40124344. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40124344

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Treatment of lung diseases via nanoparticles and nanorobots: Are these viable alternatives to overcome current treatments?
PubMed
Journal
Mater Today Bio
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
10
iCite
Relative citation ratio, by iCite
3.23, provisional
iCite
Revised in PubMed
2025-03-25
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1George MMeekha
2Boukherroub RRabah
3Sanyal AAmitav
4Szunerits SSabine

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References329

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
131815423Molecular Nanomachines Disrupt Bacterial Cell Wall, Increasing Sensitivity of Extensively Drug-Resistant Klebsiella pneumoniae to Meropenem.ACS Nano2019https://conductscience.org/library/papers/31815423PubMed
236549558Neutrophil membrane-coated nanoparticles exhibit increased antimicrobial activities in an anti-microbial resistant K. pneumonia infection model.Nanomedicine2023https://conductscience.org/library/papers/36549558PubMed
333666790Therapeutic efficacy of chitosan nanoparticles loaded with BCG-polysaccharide nucleic acid and ovalbumin on airway inflammation in asthmatic mice.Eur J Clin Microbiol Infect Dis2021https://conductscience.org/library/papers/33666790PubMed
437652327CD44 tagged hyaluronic acid - chitosan liposome carrier for the delivery of berberine and doxorubicin into lung cancer cells.Int J Biol Macromol2023https://conductscience.org/library/papers/37652327PubMed
527346486Hybrid-Actuating Macrophage-Based Microrobots for Active Cancer Therapy.Sci Rep2016https://conductscience.org/library/papers/27346486PubMed
621467058Pneumonia due to Pseudomonas aeruginosa: part I: epidemiology, clinical diagnosis, and source.Chest2011https://conductscience.org/library/papers/21467058PubMed
734474094Mesoporous silica nanoparticles for pulmonary drug delivery.Adv Drug Deliv Rev2021https://conductscience.org/library/papers/34474094PubMed
832832367High-Yield Production of Biohybrid Microalgae for On-Demand Cargo Delivery.Adv Sci (Weinh)2020https://conductscience.org/library/papers/32832367PubMed
933838013An Antibacterial Nanorobotic Approach for the Specific Targeting and Removal of Multiple Drug-Resistant Staphylococcus aureus.Small2021https://conductscience.org/library/papers/33838013PubMed
1033636597Integrin αvβ3-targeted liposomal drug delivery system for enhanced lung cancer therapy.Colloids Surf B Biointerfaces2021https://conductscience.org/library/papers/33636597PubMed
1137494584Microrobots for Biomedicine: Unsolved Challenges and Opportunities for Translation.ACS Nano2023https://conductscience.org/library/papers/37494584PubMed
1235857516Magnetically steerable bacterial microrobots moving in 3D biological matrices for stimuli-responsive cargo delivery.Sci Adv2022https://conductscience.org/library/papers/35857516PubMed
1335393247Phase II Trial of Combination Nab-paclitaxel and Gemcitabine in Non-squamous Non-small Cell Lung Cancer After Progression on Platinum and Pemetrexed.Clin Lung Cancer2022https://conductscience.org/library/papers/35393247PubMed
1433341460Nanotechnology in pulmonary medicine.Curr Opin Pharmacol2021https://conductscience.org/library/papers/33341460PubMed
1535112802
Nano-in-Microparticles for Aerosol Delivery of Antibiotic-Loaded, Fucose-Derivatized, and Macrophage-Targeted Liposomes to Combat Mycobacterial Infections: In Vitro Deposition, Pulmonary Barrier Interactions, and Targeted Delivery.
Adv Healthc Mater2022https://conductscience.org/library/papers/35112802PubMed
1638626916Superparamagnetic Iron Oxide Nanoparticles Reprogram the Tumor Microenvironment and Reduce Lung Cancer Regrowth after Crizotinib Treatment.ACS Nano2024https://conductscience.org/library/papers/38626916PubMed
1736678633Inhalable Polymeric Nanoparticles for Pulmonary Delivery of Antimicrobial Peptide SET-M33: Antibacterial Activity and Toxicity In Vitro and In Vivo.Pharmaceutics2022https://conductscience.org/library/papers/36678633PubMed
1833277608Engineering precision nanoparticles for drug delivery.Nat Rev Drug Discov2021https://conductscience.org/library/papers/33277608PubMed
1931660180Errors in inhaler use related to devices and to inhalation technique among patients with chronic obstructive pulmonary disease in primary health care.Nurs Open2019https://conductscience.org/library/papers/31660180PubMed
2024836950X-ray CT and pneumonia inhibition properties of gold-silver nanoparticles for targeting MRSA induced pneumonia.Biomaterials2014https://conductscience.org/library/papers/24836950PubMed

See all 329 referencesDownload CSV of references

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.

PMIDTitleJournalYearIn PapersSource
42194071Biomolecular Interfaces in Targeted Nano-Drug Delivery: Molecular Recognition, Signaling Modulation, and Translational Pathways.Biomolecules2026https://conductscience.org/library/papers/42194071PubMed
41424454Nasal Delivery of Phytochemicals Using Nanocarriers: Therapeutic Opportunities and Translational Challenges.Int J Nanomedicine2025https://conductscience.org/library/papers/41424454PubMed
41003423Bio-Functional Nanomaterials for Enhanced Lung Cancer Therapy: The Synergistic Roles of Vitamins D and K.J Funct Biomater2025https://conductscience.org/library/papers/41003423PubMed
40733101Inhalable Nanotechnology-Based Drug Delivery Systems for the Treatment of Inflammatory Lung Diseases.Pharmaceutics2025https://conductscience.org/library/papers/40733101PubMed
40471989Assessing the biomedical applicability of biogenically synthesized AuNPs using Salvia splendens extract.PLoS One2025https://conductscience.org/library/papers/40471989PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40124344

GET https://conductscience.org/api/papers/v1/40124344/references?page=2